AGP Picks
View all

Your daily news update on Asia and the Pacific

Provided by AGP

The Asia Pacific Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Pacific Examiner.

Press releases published on April 21, 2026

Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting
ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026
Physical AI Market Set to Hit $15.24 Billion by 2032: Future Growth & Industry Trends
Location-based Services (LBS) and Real-time Location Systems (RTLS) Market Surges to $51.24 billion by 2030 | CAGR 8.8%
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting
Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026
Breaking 100: Aiwibi Expands to Over 100 Countries Worldwide
Precedence Research Expands Strategic Portfolio with Comprehensive Go-To-Market (GTM) as a Service Offering
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies
Outlook Therapeutics Completes Federal Dispute Resolution (FDR) Meeting with FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
Tamatem 收购 Playable Factory: 进军广告技术领域,加速打造人工智能优先的移动游戏平台
MAXDropshipping Launches Enhanced Fulfillment Solution for Scaling E-commerce Brands
NYSE: MMA Highlights 41-Pound Health Transformation at UFC GYM Through TrainAlta
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call
SunCar Wins Major Bid to Manage Agricultural Bank of China’s Concierge Chauffeur Services
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation  Evolution
Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia
Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial
Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Share us

on your social networks:

Sign up for:

The Asia Pacific Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.